Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00409851 · ClinicalTrials.gov registry record · Phase 3
One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension
A Phase 3 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,293
- Enrollment target
NCT00409851: Completed Phase 3 study, sponsored by Novartis.
NCT00409851 is a Phase 3 study that has completed, run by Novartis. The registered enrollment target is 1,293 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (67% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00409851, a Phase 3 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,293 participants
- Enrollment target
Study Summary
A ONE YEAR SAFETY STUDY FOR PATIENTS WHO COMPLETE STUDY VAA489A2201.
Interventions
- DRUG valsartan+amlodipine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,293 participants |
| Start Date | 2003-04 |
| Est. Completion | 2005-03 |
| Phase | Phase 3 |
What the finished NCT00409851 record still lists
NCT00409851 is an interventional study that assigns participants to a tested intervention. Its 1,293 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (67% higher).
The record links to 0 conditions, and to 1 intervention - of which valsartan+amlodipine is the first listed.
NCT00409851 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00409851 about?
NCT00409851 is a clinical study titled "One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension". A ONE YEAR SAFETY STUDY FOR PATIENTS WHO COMPLETE STUDY VAA489A2201.
What is the current status of trial NCT00409851?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,293 participants. The study started on 2003-04. Estimated completion is 2005-03.
What interventions are being tested in trial NCT00409851?
The interventions under investigation include: valsartan+amlodipine (DRUG).
Who is sponsoring clinical trial NCT00409851?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00409851's enrollment target sits among peer trials
1,293 196th of 2000 higher than 1,805 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05812807 · 1,295 participants · Phase 3
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
- NCT05595642 · 1,290 participants · Phase 3
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia